paliperidone palmitate LAI
Selected indexed studies
- Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia. (Am J Psychiatry, 2020) [PMID:31838873]
- Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview. (CNS Drugs, 2021) [PMID:33507525]
- Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis. (CNS Drugs, 2021) [PMID:33909272]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia. (2020) pubmed
- Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview. (2021) pubmed
- Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials. (2024) pubmed
- Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis. (2021) pubmed
- Is paliperidone palmitate more effective than other long-acting injectable antipsychotics? (2018) pubmed
- Accidental Overdose of Paliperidone Palmitate. (2019) pubmed
- Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia. (2019) pubmed
- The effect of paliperidone palmitate long-acting injectable (PP-LAI) on "non-core" symptoms of schizophrenia: a retrospective, collaborative, multicenter study in the "real world" everyday clinical practice. (2021) pubmed
- A new paliperidone palmitate formulation: how is it different and where does it fit in our array of choices for long-acting formulations of risperidone and paliperidone? (2025) pubmed
- Paliperidone Palmitate: A Breakthrough Treatment for Schizophrenia? A Review on Patient Adherence Levels, Healthcare Resource Utilization and Costs. (2023) pubmed